The estimated Net Worth of Keith Crandell is at least $12.9 Million dollars as of 12 June 2024. Mr. Crandell owns over 7,777 units of Quanterix Corp stock worth over $168,099 and over the last 21 years he sold QTRX stock worth over $12,570,450. In addition, he makes $139,479 as Independent Director at Quanterix Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Crandell QTRX stock SEC Form 4 insiders trading
Keith has made over 10 trades of the Quanterix Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 7,777 units of QTRX stock worth $93,868 on 12 June 2024.
The largest trade he's ever made was buying 400,000 units of Quanterix Corp stock on 26 October 2015 worth over $2,000,000. On average, Keith trades about 26,293 units every 70 days since 2003. As of 12 June 2024 he still owns at least 13,927 units of Quanterix Corp stock.
You can see the complete history of Mr. Crandell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Keith Crandell biography
Keith L. Crandell serves as Independent Director of the Company. Mr. Crandell has served as a managing director of ARCH Venture Partners, a venture capital firm focused on early-stage technology companies. He serves on the board of directors of Twist Bioscience Corporation, a publicly traded synthetic biology company. From 2007 to 2019, he served on the board of directors of Adesto Technologies Corporation, a publicly traded provider of application specific and ultra-low power non-volatile memory products. He is also a director of several private companies and he also serves as a director of the Illinois Venture Capital Association. Mr. Crandell has a B.S. degree in chemistry and mathematics from St. Lawrence University, an M.S. degree in chemistry from the University of Texas at Arlington and an M.B.A. from the University of Chicago. Mr. Crandell's qualifications for service as a member of our board of directors include his financial expertise and his substantial experience as an investor in emerging companies.
What is the salary of Keith Crandell?
As the Independent Director of Quanterix Corp, the total compensation of Keith Crandell at Quanterix Corp is $139,479. There are 10 executives at Quanterix Corp getting paid more, with E. Kevin Hrusovsky having the highest compensation of $3,631,000.
What's Keith Crandell's mailing address?
Keith's mailing address filed with the SEC is 8755 W Higgins Rd #1025, Chicago, IL 60631, USA.
Insiders trading at Quanterix Corp
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister, and Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
What does Quanterix Corp do?
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
What does Quanterix Corp's logo look like?
Complete history of Mr. Crandell stock trades at Adesto Technologies, Illumina Inc, Quanterix Corp, Twist Bioscience Corp, and 908 Devices
Quanterix Corp executives and stock owners
Quanterix Corp executives and other stock owners filed with the SEC include:
-
E. Kevin Hrusovsky,
Chairman of the Board, President, Chief Executive Officer -
John Fry,
General Counsel, Secretary -
Amol Chaubal,
Chief Financial Officer -
E. Kevin Hrusovsky,
Chairman & CEO -
Dawn Mattoon,
Senior Vice President - Research Products -
David Duffy,
Senior Vice President, Research & Development and Chief Technology Officer -
Sarah Hlavinka,
Independent Director -
Mark Roskey,
Senior Vice President - Commercial and Accelerator -
Martin Madaus,
Lead Independent Director -
Paul Meister,
Independent Director -
Keith Crandell,
Independent Director -
Marijn Dekkers,
Independent Director -
David Walt,
Independent Director -
Dr. David R. Walt Ph.D.,
Co-Founder, Chairman of Scientific Advisory Board & Independent Director -
William Geist,
Chief Operating Officer -
Dr. Masoud Toloue Ph.D.,
Pres, CEO & Director -
Dr. Dawn R. Mattoon Ph.D.,
Sr. VP of Diagnostics -
Dr. Mark T. Roskey Ph.D.,
Sr. VP of Strategic Partnerships -
Dr. David C. Duffy Ph.D.,
Sr. VP of R&D and CTO -
Michael A. Doyle,
CFO & Treasurer -
Masoud Toloue,
Pres & Head of Diagnostics Bus. -
David Panzerella,
VP of Sales -
William Geist,
Chief Operating Officer -
Bruce J. Bal,
VP of Operations, Service & Quality -
John J. Fry,
Gen. Counsel & Corp. Sec. -
Brian J Blaser,
-
Shawn Stetson,
Interim CFO and Treasurer -
Venture Fund Vi Lparch Vent...,
-
Ventures Fund 2004 L P Flag...,
-
Capital Venture Investors, ...,
-
Ernest Orticerio,
SVP Finance and Corporate Dev -
Douglas G. Cole,
-
John M Connolly,
-
Jackson Streeter,
SVP, Corp Dev & Strategy -
Bruce J Bal,
VP of Ops, Service and Quality -
Joseph Driscoll,
Chief Financial Officer -
Amee Desjourdy,
Chief Human Resource Officer -
Laurie J Olson,
-
Michael A Doyle,
CFO and Treasurer -
Masoud Toloue,
President & CEO -
Karen Flynn,
-
William P Donnelly,
-
Vandana Sriram,
Chief Financial Officer -
Jeffrey Thomas Elliott,